Robert Eugene Watson - 28 Jul 2025 Form 4 Insider Report for CEL SCI CORP (CVM)

Reporting relationship
Director
Issuer ticker
CVM
Reported as of
28 Jul 2025
Net transaction value
+$40
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Jul 2025, 17:20:52 UTC
Prior SEC filing
29 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Robert Watson

Key filing fact

Robert Eugene Watson filed Form 4 for CEL SCI CORP (CVM) on 29 Jul 2025.

Key facts

  • This page summarizes Robert Eugene Watson's Form 4 filing for CEL SCI CORP (CVM).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 29 Jul 2025, 17:20.

Change

  • Previous filing in this sequence was filed on 29 Jul 2025.
  • Current net transaction value: +$40.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001511858 Primary reporting owner

Watson Robert Eugene

Relationship
Director
Address
8229 BOONE BLVD, SUITE 802, VIENNA
Signature
Robert Watson
Signature date
29 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVM transaction Derivative

Options

Award

Transaction value
$40
Shares
+4,000
Change %
+17%
Price
$0.0100
Shares after
27,266
Date
28 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,000
Exercise price
$8.20
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options vest in three (3) equal annual installments commencing one year after the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .